In the current study, we observed stronger TGF-β expression in chemoresistant osteosarcoma patients, and in vitro TGF-β treatment obviously strengthened the multidrug resistance of osteosarcoma cell lines. This evidence concerns the gene TGFB1 and osteosarcoma.